<!doctype html>
<html lang="en"><head>
<meta charset="utf-8"/><meta name="viewport" content="width=device-width,initial-scale=1"/>
<link rel="stylesheet" href="/newsletter/style.css"/>
<title>CHO Plus Obtains U.S. Patent for Improved Production of Proteins Using Engineered Yeast Cells — Newsletter</title>
</head><body>
<div class="container">
  <div class="header">
    <h1 style="margin:0;font-size:28px">Newsletter</h1>
    <a class="btn" href="/newsletter/">Home</a>
  </div>
  <div class="card">
    <h2 style="margin-top:0">CHO Plus Obtains U.S. Patent for Improved Production of Proteins Using Engineered Yeast Cells</h2>
    <div class="badge">2025-09-09T12:07:00+00:00</div>
    <ul>
      <li>09, 2025 (GLOBE NEWSWIRE) -- CHO Plus, Inc.</li>
<li>Now we have an offering that could improve productivity for food ingredients and other industrial products via engineered yeast cells.” Recent results from CHO Plus for pharmaceutical manufacturing demonstrate that our e</li>
<li>12,404,502 has been issued by the United States Patent and Trademark Office.</li>
<li>We continue to attract interest in our mammalian cell technologies, such as for CHO cells and HEK-293 cells.</li>
<li>Patent No.</li>
<li>About CHO Plus, Inc.</li>
<li>(www.CHO-Plus.com), a leading developer of biopharmaceutical manufacturing technology, announced that U.S.</li>
    </ul>
    <p>
      <a class="btn" href="https://twitter.com/intent/tweet?text=CHO Plus Obtains U.S. Patent for Improved Production of Proteins Using Engineered Yeast Cells\n• 09, 2025 (GLOBE NEWSWIRE) -- CHO Plus, Inc.\n• Now we have an offering that could improve productivity for food ingredients and other industrial products via engineered yeast cells.” Recent results from CHO Plus for pharmaceutical manufacturing demonstrate that our e\n• 12,404,502 has been issued by the United States Patent and Trademark Office.\n• We continue to attract interest in our mammalian cell technologies, such as for CHO cells and HEK-293 cells.\n• Patent No.\n• About CHO Plus, Inc.\n• (www.CHO-Plus.com), a leading developer of biopharmaceutical manufacturing technology, announced that U.S." target="_blank" rel="noopener">Tweet bullets</a>
      &nbsp;&nbsp;
      <a href="https://finance.yahoo.com/news/cho-plus-obtains-u-patent-120700941.html" target="_blank" rel="noopener nofollow">finance.yahoo.com</a>
    </p>
  </div>
  <div class="footer">Built from digest_5bullets.md</div>
</div>
</body></html>